FDA Clearance Tracker · P170027-S002
TherOx Downstream System
Last checked: Nov 20, 2026Latest source record: Mar 11, 2020 (this decision)Source: openFDAMethods & limitations
Decided
Mar 11, 2020
Approved
Time to decision
205 days
Received Aug 19, 2019. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track
Device class
Class III
The decision
- FDA number
- P170027-S002
- Device name
- TherOx Downstream System
- Applicant
- Zoll Circulation, Inc.
- Applicant location
- San Jose, CA
- Received
- Aug 19, 2019
- Decided
- Mar 11, 2020
- Decision
- Approved
- Supplement type
- Normal 180 Day Track
- Reason for supplement
- Change Design/Components/Specifications/Material
- Original approval
- P170027
Device type
- Device type
- System, oxygen, aqueous (MWG)
- Device class
- Class III
- Specialty
- Cardiology
FDA's approval statement
As written in FDA's record.
Approval for the DS-2 Console. The DS-2 Console uses the same cartridge as the DS-1 Console; however, it has updated hardware and software to accommodate a touchscreen display in addition to modified electrical components to comply with the EU RoHS Standard.
Source documents
Other decisions for Zoll Circulation, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K250979 · Decided Oct 15, 2025 · 198 days after receipt
Device type: Hyperthermia Monitor (NZE) · Cardiology
7 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.